human | Q5 |
P496 | ORCID iD | 0000-0002-2912-8695 |
P108 | employer | Duke University | Q168751 |
P735 | given name | Peter | Q2793400 |
Peter | Q2793400 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q34120472 | Antibody-based immunotherapy for malignant glioma |
Q90986207 | Antigen-loaded monocyte administration induces potent therapeutic antitumor T cell responses |
Q28083907 | Are BiTEs the "missing link" in cancer therapy? |
Q91736550 | Brain immunology and immunotherapy in brain tumours |
Q89573873 | CAR T cells and checkpoint inhibition for the treatment of glioblastoma |
Q90326760 | CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response |
Q48248131 | Editorial: Turning fluorescence into black and white |
Q38953017 | Embracing rejection: Immunologic trends in brain metastasis |
Q50056454 | Enhancing Radiation Therapy Through Cherenkov Light-Activated Phototherapy. |
Q35114086 | Immunotherapy for malignant glioma |
Q42149055 | Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors |
Q112296925 | Preclinical Modeling of Surgery and Steroid Therapy for Glioblastoma Reveals Changes in Immunophenotype that are Associated with Tumor Growth and Outcome |
Q43051467 | Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhage |
Q47156351 | Single fraction stereotactic radiosurgery for multiple brain metastases |
Q97540672 | The intersection between immunotherapy and laser interstitial thermal therapy: a multipronged future of neuro-oncology |
Q93371746 | Upfront Magnetic Resonance Imaging-Guided Stereotactic Laser-Ablation in Newly Diagnosed Glioblastoma: A Multicenter Review of Survival Outcomes Compared to a Matched Cohort of Biopsy-Only Patients |
Search more.